EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Prevalence of alpha-synuclein seeding activity in the Olfactory Mucosa following SARS-CoV-2 infection: results from a pilot study

Beatrice Heim, Klaus Seppi, Nicolas De Cleene, Matilde Bongianni, Erika Bronzato, Clancy Cerejo, Frank Jagusch, Philipp Kindl, Judith Löffler-Ragg, Günter Weiss, Timo Gottfried, Joachim Schmutzhard und 2 weitere

Acta Neuropathologica · 2026

DOI: 10.1007/s00401-026-03104-4 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Acta Neuropathologica, 2026. Verfasst von Beatrice Heim und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria. Hauptthemen laut MEDLINE: alpha-Synuclein, COVID-19, Olfaction Disorders, Olfactory Mucosa. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Olfactory dysfunction (OD) is a hallmark of SARS-CoV-2-infection where it is believed to result from neuroinflammation induced by viral invasion via the olfactory mucosa (OM). Hyposmia also affects the majority of patients with Parkinson’s disease (PD) where it is caused by α-synuclein (aSyn) pathology in the olfactory system, and aSyn-seeding-activity can be detected in the OM using aSyn-seeding-amplification-assays (aSyn-SAA). The present pilot study aimed to investigate whether SARS-CoV-2-infection induces local aSyn-misfolding and -aggregation in OM samples using aSyn-SAA. We conducted an observational study including PD patients (n = 51), individuals with a history of documented symptomatic SARS-CoV-2-infection (post-COVID; n = 95), and healthy controls (HC; n = 42). Post-COVID-participants were stratified based on persistent OD (COVID+OD; n = 42) or normal olfaction (COVID–OD; n = 53) using Sniffin’-Sticks-Identification (SSI) and -Discrimination (SSD) tests. OM samples were obtained by ENT specialists and analyzed by aSyn-SAA at the University of Verona. Clinical phenotyping included MDS-UPDRS, MoCA, and the Innsbruck-RBD-Inventory. OM-SAA positivity rates were significantly different between PD and both post-COVID-participants and HCs (80.4% vs 24.2% vs 11.9%; p < 0.001). Within the post-COVID-group, positivity rates were higher in COVID+OD vs COVID–OD (35.7% vs 15.1%; p = 0.030), and COVID+OD differed from HC ( p = 0.030), while COVID–OD did not ( p = 0.65). Among post-COVID-participants, aSyn-SAA positivity was associated with lower SSI ( p = 0.007) and SSD ( p < 0.001) scores, but not with MDS-UPDRS, MoCA, or RBD measures. OM-SAA-positivity was enriched among individuals with persistent post-COVID-OD and correlated with olfactory impairment. These findings support the hypothesis that neuroinflammation following SARS-COV-2-infection might promote local aSyn-aggregation. The biological and prognostic relevance of OM-SAA positivity is unknown and needs further prospective investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinCOVID-19Olfaction DisordersOlfactory MucosaAgedAged, 80 and overFemaleHumansMaleMiddle AgedParkinson DiseasePilot ProjectsPrevalenceSARS-CoV-2Protein Folding

Stichwörter der Autor:innen

COVID-19HyposmiaOlfactionOlfactory mucosaParkinson’s diseaseRT-QuICα-synuclein

Substanzen

alpha-Synuclein

Autor:innen und Institutionen

  • Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.
  • Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria. klaus.seppi@i-med.ac.at.
  • Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
  • Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.
  • Department of Otorhinolaryngology, Medical University of Innsbruck, Innsbruck, Austria.
  • Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria. werner.poewe@i-med.ac.at.

Förderung

  • Austrian Science Fund

Zitieren

APA

Heim, B., Seppi, K., De Cleene, N., Bongianni, M., Bronzato, E., Cerejo, C., Jagusch, F., Kindl, P., Löffler-Ragg, J., Weiss, G., Gottfried, T., Schmutzhard, J., Zanusso, G., & Poewe, W. (2026). Prevalence of alpha-synuclein seeding activity in the Olfactory Mucosa following SARS-CoV-2 infection: results from a pilot study. Acta Neuropathologica. https://doi.org/10.1007/s00401-026-03104-4

Vancouver

Heim B, Seppi K, De Cleene N, Bongianni M, Bronzato E, Cerejo C, et al. Prevalence of alpha-synuclein seeding activity in the Olfactory Mucosa following SARS-CoV-2 infection: results from a pilot study. Acta Neuropathologica. 2026. doi:10.1007/s00401-026-03104-4

BibTeX
@article{Heim2026,
  author = {Heim, Beatrice and Seppi, Klaus and De Cleene, Nicolas and Bongianni, Matilde and Bronzato, Erika and Cerejo, Clancy and Jagusch, Frank and Kindl, Philipp and Löffler-Ragg, Judith and Weiss, Günter and Gottfried, Timo and Schmutzhard, Joachim and Zanusso, Gianluigi and Poewe, Werner},
  title = {Prevalence of alpha-synuclein seeding activity in the Olfactory Mucosa following SARS-CoV-2 infection: results from a pilot study},
  journal = {Acta Neuropathologica},
  year = {2026},
  doi = {10.1007/s00401-026-03104-4}
}
Kostenlos starten →